THE CANNABIS INNOVATION CENTER
The Cannabis Innovation center is an Israeli biotech innovation group with a specialty in the fields of Cannabis with main strengths in the pharmaceutical space through its vast experience and activities.
Stero Biotechs – a pharmaceutical startup company developing a CBD-based steroid sparing treatment with a strong IP, ongoing phase 2a clinical trials with more indications in the pipeline for 2020
CannaLean Biotechs – a pharmaceutical startup company developing a novel formulation to lower the lipid blood levels in patients with dyslipidemia with 3 successful pre-clinical trials with 2 clinical trials in the pipeline at H2 of 2020
CannaMore Biotechs – a pre-clinical and clinical stage research platform company committed to the development of novel and improved cannabis-based treatment options with a groundbreaking partnership with the largest HMO in Israel with clinical trials in the pipeline for 2020
BioSeed – a biotech & Cannabis startup incubator that provides the perfect eco-system for startup companies in the vast field of Biotech and Cannabis in particular, with dedication to support early stage startups, providing them all the necessary tools guidance ,R&D support and more. BioSeedXL specializes in biotech with an emphasis on Cannabis in the fields of pharma, medical device, diagnostics, OTC and cosmetics.
CannaDu – an exclusive Biotech Venture Capital fund, focused on Cannabis investments in fields of Pharmaceuticals, wellness, medical applications & devices.
THE GROUP's CLINICAL TRIALS
| # | Indication | phase |
|---|---|---|
| 1 | GvHD prevention | 2b |
| 2 | Crohn's Disease | 2a |
| 3 | Urticaria | 2a |
| 4 | Cholesterol | 2a |
| 5 | Paucities | 2a |
| 6 | Bronchiolitis Obliterans treatment | 2a |
| 7 | Triglycerides | 2a |
| 8 | GvHD treatment | 2b |
| 9 | COPD & Asthma /Autoimmune | 2a |
| 10 | Ulcerative colitis | 2a |
| 11 | Bronchiolitis Obliterans prevention | 2a |
| 12 | GvHD prevention | 3 |
| 13 | Arthritis | 2a |